EDIT: Editas Medicine Inc Company Profile & Statistics

About

Editas Medicine is a development-stage genome editing biotech, which makes medicines to treat serious diseases using its proprietary genome editing platform based on the unique Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology. Though the company's discovery efforts target several disease areas, ocular diseases and engineered cell medicines are two such zones where its pipeline is most mature.

Info & Links

CEO

Gilmore O¿Neill

Headquarters

11 Hurley Street
Cambridge, MA 02141, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

265

Editas Medicine Inc Statistics

Valuation Measures

Market Capitalization²

111.03M

Enterprise Value

15.20M

Enterprise Value/EBITDA(ttm)

-0.07

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.92

Price to Book(mrq)

0.68

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-340.96%

Profit Margin(ttm)

-30134.71%

Return on Equity(ttm)

-80.13%

Return on Invested Capital(ttm)

-90.97%

Return on Assets(ttm)

-50.99%

Income Statement

Revenue(ttm)

61.76M

Revenue Per Share(ttm)

0.75

Gross Profit(ttm)

61.76M

EBITDA(ttm)³

-229.65M

Net Income Available to Common(ttm)

-210.57M

Diluted EPS(ttm)

-2.56

Share Statistics

Beta (5Y Monthly)

1.86

52-Week Change

-87.83%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

82.55M

Dividend Yield

0.00%

Float⁴

80.98M

% Held by Insiders

1.90%

% Held by Institutions

71.90%

Balance Sheet

Total Cash(mrq)

265.09M

Total Cash Per Share(mrq)

3.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.75%

Quick Ratio(mrq)

3.75%

Book Value Per Share(mrq)

2.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.93

Free Cash Flow(ytd)

-167.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EDIT

Editas Medicine Inc

Editas Medicine Inc Profile